News
Updates brought by the new Guidance on the characterisation and risk assessment of microorganisms used in the food chain
Following its agenda to regulate the Food and Feed industry with up-to-date regulatory texts, the EFSA published this 4th November 2025 an update on the guidance on the characterisation and risk assessment of microorganisms used in the food chain. This text aims to follow the industrial mutations and their new research and development advances, but also the state of the art of scientific technics and the new safety discoveries.
GenoScreen and Clear Labs Announce the Launch of Clear Dx™ Deeplex® Myc-TB, an Automated Genomic Solution for Mycobacterium Characterization and TB Drug Resistance Detection
GenoScreen announces the launch of Clear Dx™ Deeplex® Myc-TB, developed in collaboration with Clear Labs.
How to scientifically and regulatory validate a probiotic or postbiotic Strain (EFSA, FDA)?
What are the requirements for marketing a probiotic or postbiotic strain?
Developing supplements or functional foods containing a biotic strain involves much more than simply demonstrating their effectiveness. This process is essential for obtaining regulatory approvals from authorities such as the European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) :
What is the QPS list?
From prebiotic to LBP: Measuring functional effects in the gut microbiome
An imbalanced microbiome is not only characterized by a lack of diversity or abundance of species. What truly matters are the functions expressed:
Updated guidelines for Novel Food submissions (EU) 2015/2283
The 1st of February 2025 entered into force the “Guidance on the scientific requirements for an application of a novel food in the context of Regulation (EU) 2015/2283”.
How to prove the efficacy of a probiotic or postbiotic using genomics?
Biotics — whether prebiotics, probiotics, or postbiotics — are at the core of nutritional and therapeutic strategies aimed at preserving or restoring gut microbiota balance. However, with increasing regulatory requirements (EFSA, FDA) and growing market competition, it is crucial to demonstrate their efficacy through robust scientific evidence.